STOCK TITAN

CRNX (NASDAQ: CRNX) files Rule 144: 20,900-share exercise, prior 10b5-1 sales

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRNX filing reports proposed and recent sales of Common Stock by an affiliated holder. The filing lists an exercise of stock options for 20,900 shares on 04/14/2026 (cash exercise) and multiple 10b5-1 sales executed by Jeff Knight: 9,911 shares on 03/16/2026, 85,163 shares on 04/08/2026, and 4,434 shares on 04/13/2026, with cash proceeds shown per trade.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice tied to option exercise and scheduled 10b5-1 sales.

The filing records an exercise of stock options for 20,900 shares on 04/14/2026 and lists prior 10b5-1 dispositions by Jeff Knight on 03/16/2026, 04/08/2026, and 04/13/2026. The 10b5-1 entries show executed share counts and gross proceeds per trade.

These disclosures are procedural under Rule 144 and do not, by themselves, indicate discretionary trading outside a prearranged plan. Subsequent filings would show any additional dispositions or changes to planned sales.

Option exercise 20,900 shares exercise of stock options on 04/14/2026 (cash exercise)
10b5-1 sale 9,911 shares sale on 03/16/2026 with proceeds $370,411.47
10b5-1 sale 85,163 shares sale on 04/08/2026 with proceeds $3,414,701.10
10b5-1 sale 4,434 shares sale on 04/13/2026 with proceeds $177,438.04
Rule 144 regulatory
"144: Securities To Be Sold"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 regulatory
"10b5-1 Sales for JEFF KNIGHT"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
exercise of stock options financial
"Exercise of Stock Options | Issuer | 20900 | 04/14/2026"

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CRNX's Form 144 disclose about insider sales?

It discloses an exercise and recent scheduled sales totaling multiple share lots. The filing lists a 20,900-share option exercise on 04/14/2026 and 10b5-1 sales of 9,911, 85,163, and 4,434 shares on the dates shown.

Who executed the 10b5-1 sales in the CRNX filing?

The 10b5-1 sales were executed by Jeff Knight. The filing names Jeff Knight and shows sales on 03/16/2026, 04/08/2026, and 04/13/2026 with share counts and proceeds.

What proceeds are reported for the 10b5-1 trades in CRNX's filing?

Gross proceeds per trade are listed alongside each sale. The filing shows proceeds of $370,411.47, $3,414,701.10, and $177,438.04 for the three respective 10b5-1 transactions.

Does the filing state how the 20,900-share option exercise was funded?

Yes. The exercise of 20,900 shares on 04/14/2026 is shown as a cash exercise in the filing's securities-to-be-sold section.

Which broker-dealer is listed for the proposed sale activity?

The filing lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker-dealer associated with the securities to be sold in the document.